Prohibition Partners · Free weekly briefing
International Cannabis Weekly
The week’s global cannabis news, read through the analyst’s lens — one sentence per story, sourced.
330
7 regions32 stories1 publisher15 countries
Top story
Switzerland setting new legal and scientific standards for cannabis
Switzerland’s pioneering cannabis pilot project has developed into Europe’s most advanced and accessible adult-use framework throughout 2023.
CHAdult-uselink no longer available
Europe
5 stories- UK health professionals show favourable stance on medical cannabis
GBMedicallink no longer available
- France's struggle to advance medical cannabis initiatives highlighted
FRMedicallink no longer available
- Cannamedical Cannabis Survey 2023/24 launched to improve patient care
Events & Industrylink no longer available
- Somaí Pharmaceuticals and Canify launch cannabinoid product line in Germany
DEBusiness & Investmentlink no longer available
- Belgium's Florapoint CBD outlets rebrand as Green Grown Cannabis store
BEBusiness & Investmentlink no longer available
United States
6 stories- Florida GOP Senator introduces bill for medical cannabis tax relief
USRegulationlink no longer available
- Nebraska activists highlight medical cannabis legalisation petition progress
USRegulationlink no longer available
- Delaware legislation aims to broaden medical cannabis access
USMedicallink no longer available
- Federal authorities and cannabis industry extend lawsuit deadline on prohibition
USRegulationlink no longer available
- Wisconsin proposals seek cannabis legalisation despite federal prohibition
USRegulationlink no longer available
- Six synthetic cannabinoids classified as Schedule 1 to prevent public safety hazard
USRegulationlink no longer available
Canada
6 stories- Organigram's Q4 revenue soars with pre-rolls and edibles securing #2 market position
CABusiness & Investmentlink no longer available
- Alberta allows cannabis sales at adults-only events
CAAdult-uselink no longer available
- Licensed retailers seek inclusion in Ontario's mail-order cannabis monopoly
CARegulationlink no longer available
- Health Canada approves EEG-driven research model for cannabis effects exploration
CAHealth & Sciencelink no longer available
- Shiny Health & Wellness finalises acquisition deal with Stash & Co
CABusiness & Investmentlink no longer available
- Motif Labs appoints new Chief Manufacturing Officer
CABusiness & Investmentlink no longer available
LATAM & Caribbean
3 stories- Colombia's President condemns senate for halting cannabis legalisation
CORegulationlink no longer available
- Argentina approves incorporating seeds and hemp into flours and oils
ARHemp & CBDlink no longer available
- Colombia-based Blueberries Medical unveils C$2 million private placement
COBusiness & Investmentlink no longer available
Africa & Middle East
4 stories- MGC's Artemic approved in Saudi Arabia and Panaxia stock skyrockets in 2023
SABusiness & Investmentlink no longer available
- São Vicente's first medicinal cannabis collaboration emphasises public awareness
CVMedicallink no longer available
- Ghana's parliament approves legislation to regulate cannabis for industrial use
GHRegulationlink no longer available
- South African province pledges support for newly licensed hemp growers
ZAHemp & CBDlink no longer available
APAC
2 stories- Epsilon chairman vote cancelled as company calls in administrator
Business & Investmentlink no longer available
- Japan's health ministry bans 38 products with cannabis-like compounds
JPRegulationlink no longer available
Oceania
2 stories- CannMart to facilitate inaugural international export of medical cannabis to Australia
AUMedicallink no longer available
- New Zealand's Greenfern Industries approved for first commercial cannabis harvest
NZAdult-uselink no longer available
Stocks
- 2023 stock report
Business of CannabisBusiness & Investment
Never miss an issue
International Cannabis Weekly in your inbox every week — the global developments that move the market, with the data behind them.
From the research library
Global Medical Cannabis Market Review
14 key international markets, 2025–2030. Sizing, forecasts and regulatory outlook.
From £1,265
View report